RKDA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Arcadia Biosciences Inc (RKDA) is not a strong buy at this time for a beginner investor with a long-term strategy. The company's financial performance is weak, with significant declines in revenue, net income, and EPS. Additionally, there are no positive trading signals or recent news catalysts to support a bullish outlook. Technical indicators suggest a bearish trend, and there is no significant sentiment from hedge funds, insiders, or Congress trading data. Given the lack of positive catalysts and the company's poor financials, holding off on investing in RKDA is recommended.
The MACD histogram is positive and expanding, but RSI is neutral at 23.016, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key support levels, with a pivot at 1.894 and S1 at 1.731. Overall, the technical indicators suggest a bearish trend.
NULL identified. No recent news, no significant insider or hedge fund activity, and no recent Congress trading data.
Weak financial performance in Q3 2025, with revenue down 15.29% YoY, net income down 153.10% YoY, and EPS down 152.54% YoY. Gross margin also declined by 25.14%. Bearish moving averages and lack of positive trading signals further weigh on the stock.
In Q3 2025, revenue dropped to $1,302,000 (-15.29% YoY), net income dropped to $856,000 (-153.10% YoY), EPS dropped to 0.62 (-152.54% YoY), and gross margin fell to 32.1 (-25.14% YoY). The financials indicate significant underperformance.
No recent analyst ratings or price target changes available.
